Saúl Alberto Díaz-Pérez

Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2

J. Muñóz-Valle, J. Hernández-Bello, Andrea Carolina Machado-Sulbarán, 2021, Vaccines.

Comparison of three different COVID-19 vaccine platforms (CoronaVac, BTN162b2, and Ad5-nCoV) in individuals with and without prior COVID-19: Reactogenicity and neutralizing antibodies

J. Muñóz-Valle, J. Hernández-Bello, Andrea Carolina Machado-Sulbarán, 2022, Immunology Letters.

Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort Study

J. Muñóz-Valle, M. García-Chagollán, J. Hernández-Bello, 2022, Journal of inflammation research.

Efficacy and Safety of Heterologous Booster Vaccination after Ad5-nCoV (CanSino Biologics) Vaccine: A Preliminary Descriptive Study

J. Muñóz-Valle, J. Hernández-Bello, G. A. Sánchez-Zuno, 2022, Vaccines.

Vitamin D in Depression: A Potential Bioactive Agent to Reduce Suicide and Suicide Attempt Risk

J. Muñóz-Valle, J. Hernández-Bello, Francisco Javier Turrubiates-Hernández, 2023, Nutrients.

BNT162b2 Vaccination after SARS-CoV-2 Infection Changes the Dynamics of Total and Neutralizing Antibodies against SARS-CoV-2: A 6-Month Prospective Cohort Study

J. Muñóz-Valle, J. Hernández-Bello, J. Hern, 2023, Vaccines.